Advagraf
Showing 1 - 25 of 123
Acute Graft Rejection, Diabetes Trial in Vancouver (Tacrolimus)
Completed
- Acute Graft Rejection
- Diabetes
-
Vancouver, British Columbia, CanadaSt. Paul's Hospital
Nov 4, 2022
Kidney Transplant Trial in China (Tacrolimus immediate-release formulation, Tacrolimus prolonged-release formulation, Induction
Completed
- Kidney Transplant
- Tacrolimus immediate-release formulation
- +4 more
-
Beijing, China
- +13 more
Aug 3, 2022
Prophylaxis Against Liver Transplant Rejection Trial in Germany (Tacrolimus Pill, Tacrolimus capsule)
Recruiting
- Prophylaxis Against Liver Transplant Rejection
- Tacrolimus Pill
- Tacrolimus capsule
-
Aachen, Germany
- +14 more
May 16, 2022
Renal Failure, Renal Insufficiency, Renal Disease Trial in Dresden (Advagraf)
Active, not recruiting
- Renal Failure
- +3 more
- Advagraf
-
Dresden, GermanyUniversitätsklinikum Carl Gustav Carus
Aug 2, 2022
Liver Disease Trial in Groningen, Leiden, Rotterdam (Tacrolimus and Sirolimus, Tacrolimus)
Completed
- Liver Disease
- Tacrolimus and Sirolimus
- Tacrolimus
-
Groningen, Netherlands
- +2 more
Mar 17, 2022
Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Stem cell infusion
- +5 more
-
Saint Louis, MissouriWashington University
Jan 17, 2023
" SAVE Study for Fast Metabolizers Kidney Transplant Recipients"
Recruiting
- Renal Transplant Failure
- No intervention
-
Nantes, FranceCHU de Nantes
Jul 29, 2021
Renal Transplant Trial in Chapel Hill (Tacrolimus)
Completed
- Renal Transplant
-
Chapel Hill, North CarolinaUniveristy of North Carolina
Jul 18, 2022
Liver Transplantation Trial in Hamburg (Treatment 2 weeks Envarsus followed by 2 weeks Advagraf, Treatment 2 weeks Advagraf
Completed
- Liver Transplantation
- Treatment 2 weeks Envarsus followed by 2 weeks Advagraf
- Treatment 2 weeks Advagraf followed by 2 weeks Envarsus
-
Hamburg, GermanyUniversity Hospital Hamburg-Eppendorf
May 3, 2021
End-stage Renal Failure, Graft Rejection Trial in London (Tacrolimus (Kidney transplant maintenance immunosuppression), Kidney
Completed
- End-stage Renal Failure
- Graft Rejection
- Tacrolimus (Kidney transplant maintenance immunosuppression)
- Kidney transplant maintenance immunosuppression
-
London, United KingdomWest London Renal & Transplant Centre, Hammersmith Hospital
Aug 26, 2021
End-Stage Renal Disease Trial in Vancouver (Conversion to Advagraf, conversion of non-immunosuppressant drugs to once daily,
Active, not recruiting
- End-Stage Renal Disease
- Conversion to Advagraf
- +2 more
-
Vancouver, British Columbia, Canada
- +2 more
Oct 5, 2021
Evidence of Liver Transplantation Trial in Seoul (Advagraf)
Completed
- Evidence of Liver Transplantation
- Advagraf
-
Seoul, Korea, Republic ofSeoul Asan Medical Center
Feb 17, 2021
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
Renal Insufficiency, Kidney Transplantation Trial in Amsterdam, Groningen, Leiden (tacrolimus OD, mycophenolic acid,
Completed
- Renal Insufficiency
- Kidney Transplantation
- tacrolimus OD, mycophenolic acid, prednisolone
-
Amsterdam, Netherlands
- +2 more
Dec 20, 2021
Immunosuppression, Kidney Transplant Rejection, Kidney Transplant; Complications Trial in Warsaw (Tacrolimus, Unbound tacrolimus
Recruiting
- Immunosuppression
- +6 more
- Tacrolimus
- +2 more
-
Warsaw, PolandDepartment of General and Transplant Surgery, Medical University
Apr 14, 2022
Global, Multicentre, Non Interventional Advagraf Conversion
Completed
- Kidney Transplantation
-
Camperdown, New South Wales, Australia
- +128 more
Nov 10, 2022
Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid
Recruiting
- Previously Treated Myelodysplastic Syndrome
- +3 more
- Fludarabine Phosphate
- +9 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 7, 2022
Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford
Recruiting
- Allogeneic Hematopoietic Cell Transplantation (HCT)
- +5 more
- Purified regulatory T-cells (Treg) plus CD34+ HSPC
- +7 more
-
Stanford, CaliforniaStanford University
Oct 28, 2021
Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,
Active, not recruiting
- Autologous Hematopoietic Stem Cell Transplant Recipient
- +4 more
- bortezomib
- +7 more
-
Duarte, CaliforniaCity of Hope
Mar 17, 2022
Liver Failure Trial in Winnipeg (Tacrolimus)
Completed
- Liver Failure
-
Winnipeg, Manitoba, CanadaJohn Buhler Research Centre Health Sciences Centre
Jan 22, 2020
Pharmacokinetics Trial in Rennes (drug, biological, genetic, other)
Recruiting
- Pharmacokinetics
- Treatment A
- +6 more
-
Rennes, FranceCHU de Rennes
Mar 15, 2022
Liver Transplantation Trial in Taoyuan (Advagraf, Prograf)
Recruiting
- Liver Transplantation
- Advagraf
- Prograf
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Jun 4, 2020